On Tuesday, Tenaya Therapeutics Inc (NASDAQ: TNYA) opened lower -4.42% from the last session, before settling in for the closing price of $1.13. Price fluctuations for TNYA have ranged from $0.36 to $4.01 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -15.48% annually for the last half of the decade. Company’s average yearly earnings per share was noted 47.84% at the time writing. With a float of $137.66 million, this company’s outstanding shares have now reached $162.98 million.
Tenaya Therapeutics Inc (TNYA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tenaya Therapeutics Inc is 15.53%, while institutional ownership is 18.01%. The most recent insider transaction that took place on Aug 18 ’25, was worth 3,711. In this transaction SVP, Finance of this company sold 2,962 shares at a rate of $1.25, taking the stock ownership to the 95,338 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Chief Medical Officer sold 5,053 for $1.25, making the entire transaction worth $6,331. This insider now owns 172,803 shares in total.
Tenaya Therapeutics Inc (TNYA) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.3 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.37) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Check out the current performance indicators for Tenaya Therapeutics Inc (TNYA). In the past quarter, the stock posted a quick ratio of 6.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Let’s dig in a bit further. During the last 5-days, its volume was 2.28 million. That was inferior than the volume of 2.96 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 42.36%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 66.06%, which indicates a significant increase from 44.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1440 in the past 14 days, which was higher than the 0.0662 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8193, while its 200-day Moving Average is $1.0606. However, in the short run, Tenaya Therapeutics Inc’s stock first resistance to watch stands at $1.1233. Second resistance stands at $1.1667. The third major resistance level sits at $1.2033. If the price goes on to break the first support level at $1.0433, it is likely to go to the next support level at $1.0067. The third support level lies at $0.9633 if the price breaches the second support level.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
There are currently 162,976K shares outstanding in the company with a market cap of 176.01 million. Presently, the company’s annual sales total 0 K according to its annual income of -111,130 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -23,280 K.
